HLA-DRB1*alleles and symptoms associated with Heerfordt's syndrome in sarcoidosis

European Respiratory Journal

Volumn 38, Issue 5, 2011, Pages 1151-1157

  Darlington, P ^a   Tallstedt, L ^a   Padyukov, L ^a   Kockum, I ^a   Cederlunde, K ^a   Eklund, A ^a   Grunewald, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Eyes; Heerfordt's syndrome; Human leukocyte antigen; Ocular sarcoidosis; Sarcoidosis

Indexed keywords

HLA DR ANTIGEN; HLA DRB1 ANTIGEN; HLA DRB1*04 ANTIGEN; HLA-DRB1*04 ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; EYE DISEASE; EYE SARCOIDOSIS; FACIAL NERVE PARALYSIS; FEMALE; HETEROZYGOSITY; HLA TYPING; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAROTID ENLARGEMENT; PRIORITY JOURNAL; RISK FACTOR; SALIVARY GLAND DISEASE; SALIVARY GLAND HYPERTROPHY; SARCOIDOSIS; UVEITIS; GENE FREQUENCY; GENETICS; MIDDLE AGED;

ADULT; AGED; FEMALE; GENE FREQUENCY; HLA-DRB1 CHAINS; HUMANS; MALE; MIDDLE AGED; SARCOIDOSIS; UVEITIS; UVEOPAROTID FEVER; YOUNG ADULT;

EID: 80355127118     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00025011     Document Type: Article

References (32)

1. Newman LS, Rose CS, Maier LA. Medical progress - sarcoidosis. N Eng J Med 1997; 336: 1224-1234.
2. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Eng J Med 2007; 357: 2153-2165.
3. Hedfors E, LindstromF. HLA-B8/Dr3 in sarcoidosis - correlation to acute onset disease with arthritis. Tissue Antigens 1983; 22: 200-203. (Pubitemid 13048491)
4. Berlin M, Fogdell-Hahn A, Olerup O, et al. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997; 156: 1601-1605. (Pubitemid 27505531)
5. Löfgren S. Erythema nodosum: studies on etiology and pathogenesis in 185 adult cases. Acta Med Scand 1946; 124: Suppl. 174, 1-197.
6. Grunewald J, Shigematsu M, Nagai S, et al. T-cell receptor V gene expression in HLA-typed Japanese patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1995; 151: 151-156.
7. Heerfordt CF. [Über eine "Febris uveo-parotidea subchronica" an der Glandula parotis und der Uvea des Auges lokalisiert und häufug mit Paresen cerebrospinaler Nerven kompliziert.] Arch Ophthalmol 1909; 70: 254-273.
8. Waldenström J. Some observations on uveoparotitis and allied conditions with special reference to the symptoms from the nervous system. Acta Med Scand 1937; 91: 53-68.
9. Scadding JG. Sarcoidosis. London, Eyre and Spottiswoode, 1967; pp. 200-202.
10. Pietinalho A, Ohmichi M, Hiraga Y, et al. The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan - a comparative study. Sarcoidosis 1992; 9: 443-444.
11. Herbort CP, Rao NA, Mochizuki M. International criteria for the diagnosis of ocular sarcoidosis: results of the First International Workshop on Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm 2009; 17: 160-169.
12. Baughman RP, Lower EE, Kaufman AH. Ocular sarcoidosis. Semin Respir Crit Care Med 2010; 31: 452-462.
13. Rothova A. Ocular involvement in sarcoidosis. Brit J Ophthalmol 2000; 84: 110-116. (Pubitemid 30251644)
14. ATS/ERS/WASOG. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-755.
15. Zajicek JP, Scolding NJ, Foster O, et al. Central nervous system sarcoidosis diagnosis - management. QJM 1999; 92: 103-117. (Pubitemid 29097635)
16. Scadding JG. Prognosis of intrathoracic sarcoidosis in England - a review of 136 cases after 5 years observation. BMJ 1961; 2: 1165-1172.
17. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and HLA-DQA1 typing by PCR amplification with sequence-specific primers (PCRSSP) in 2 hours. Tissue Antigens 1993; 41: 119-134. (Pubitemid 23139836)
18. Sanjeevi CB, Lybrand TP, Deweese C, et al. Polymorphic amino-acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of Iddm. Diabetes 1995; 44: 125-131.
19. Kockum I, Sanjeevi CB, Eastman S, et al. Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes. Eur J Immunogenet 1999; 26: 361-372. (Pubitemid 29479003)
20. Foley PJ, McGrath DS, Puscinska E, et al. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am J Respir Cell Mol Biol 2001; 25: 272-277. (Pubitemid 32918907)
21. Grunewald J, Brynedal B, Darlington P, et al. Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients. Respir Res 2010; 11: 25.
22. Rossman MD, Thompson B, Frederick M, et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003; 73: 720-735. (Pubitemid 37271878)
23. Sato H, Woodhead FA, Ahmad T, et al. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet 2010; 19: 4100-4111.
24. Hattori N, Niimi T, Sato S, et al. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 27-32. (Pubitemid 40444731)
25. Spagnolo P, Renzoni EA, Wells AU, et al. C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis. Am J Respir Crit Care Med 2005; 172: 721-728. (Pubitemid 41324227)
26. Sato H, Williams HRT, Spagnolo P, et al. CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis. Eur Respir J 2010; 35: 324-330.
27. Fischer A, Nothnagel M, Franke A, et al. Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes. Eur Respir J 2011; 37: 610-616.
28. Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004; 169: 696-702. (Pubitemid 38338921)
29. Ohara K, Okubo A, Sasaki H, et al. Intraocular manifestations of systemic sarcoidosis. Jpn J Ophthalmol 1992; 36: 452-457. (Pubitemid 23035199)
30. Evans M, Sharma O, LaBree L, et al. Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis. Ophthalmology 2007; 114: 325-333.
31. Baughman R, Costabel U, du Bois R. Treatment of sarcoidosis. Clin Chest Med 2008; 29: 533-548. (Pubitemid 351784486)
32. Pietinalho A, Ohmichi M, Hirasawa M, et al. Familial sarcoidosis in Finland and Hokkaido, Japan - a comparative study. Respir Med 1999; 93: 408-412. (Pubitemid 29265351)